ABS has industry professionals with extensive experience in sample preparation, HPLC and mass spectrometry with a proven track record of method development/transfer and validation with over 60 peer reviewed articles.

Our scientific competence and state-of-the-art analytical equipment enables us to quickly develop accurate, precise and reliable assays.

One of the directors (Paul Taylor) was a winner of the "Young Investigator Award" by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Society in 2005

Published book chapter (Paul Taylor):
Method development and optimization of LC-MS (Chapter 2).
In: Polettini A, Applications of liquid chromatography-mass spectrometry in toxicology. London: Pharmaceutical Press 2006.

Global first methods using HPLC-tandem mass spectrometry (Published):

Taylor PJ, Jones A, Balderson G, et al. Quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry.
Clinical Chemistry (1996) Vol. 42, pages 279-285.

Taylor PJ, Johnson AG. Quantitative analysis of sirolimus (rapamycin) in blood by high-performance liquid chromatography-electrospray tandem mass spectrometry.
Journal of Chromatography B (1998), Vol. 718, pages 251-257.

Willis C, Taylor PJ, Salm P, et al. Quantification of free mycophenolic acid by high-performance liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry.
Journal of Chromatography B (2000), Vol. 748, pages 151-256.

Salm P, Taylor PJ, Jones A, et al. The measurement of PEP005 in human whole blood by HPLC-electrospray-tandem mass spectrometry [Abstract].
Therapeutic Drug Monitoring (2003) Vol. 25: page 500.

Salm P, Warnholtz CR, Lynch SV, et al. Measurement and stability of FTY720 in human whole blood by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
Journal of Chromatography B (2006), Vol. 843, pages 157-163.